Chronic kidney disease after lung transplantation in a changing era

Research output: Contribution to journalReview articlepeer-review

4 Citations (Scopus)
152 Downloads (Pure)

Abstract

Lung transplant (LTx) physicians are responsible for highly complex post-LTx care, including monitoring of kidney function and responding to kidney function loss. Better survival of the LTx population and changing patient characteristics, including older age and increased comorbidity, result in growing numbers of LTx patients with chronic kidney disease (CKD). CKD after LTx is correlated with worse survival, decreased quality of life and high costs. Challenges lie in different aspects of post-LTx renal care. First, serum creatinine form the basis for estimating renal function, under the assumption that patients have stable muscle mass. Low or changes in muscle mass is frequent in the LTx population and may lead to misclassification of CKD. Second, standardizing post-LTx monitoring of kidney function and renal care might contribute to slow down CKD progression. Third, new treatment options for CKD risk factors, such as diabetes mellitus, proteinuria and heart failure, have entered clinical practice. These new treatments have not been studied in LTx yet but are of interest for future use. In this review we will address the difficult aspects of post-LTx renal care and evaluate new and promising future approaches to slow down CKD progression.

Original languageEnglish
Article number100727
Number of pages8
JournalTransplantation Reviews
Volume36
Issue number4
Early online date15-Sept-2022
DOIs
Publication statusPublished - Dec-2022

Keywords

  • lung transplantation
  • Chronic kidney disease
  • Cardiovascular disease
  • cystatin C
  • SGLT-2 inhibitors
  • GLP-1 receptor agonist

Fingerprint

Dive into the research topics of 'Chronic kidney disease after lung transplantation in a changing era'. Together they form a unique fingerprint.

Cite this